Page last updated: 2024-08-25

voriconazole and Allergic Bronchopulmonary Mycosis

voriconazole has been researched along with Allergic Bronchopulmonary Mycosis in 146 studies

Research

Studies (146)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (6.85)29.6817
2010's111 (76.03)24.3611
2020's25 (17.12)2.80

Authors

AuthorsStudies
Bocanegra, R; Coalson, JJ; Graybill, JR; McConville, JT; Najvar, LK; Patterson, TF; Peters, JI; Tolman, JA; Wiederhold, NP; Williams, RO1
Beauchemin, C; Claveau, D; Dufresne, SF; Guinan, K; Rotstein, C1
Jorwal, P; Khanna, P; Kodan, P; Ray, A; Sarda, R; Singh, G; Sinha, S; Swain, S; Trikha, A; Vyas, S; Wig, N; Xess, I1
Bae, NY; Byun, JM; Choe, PG; Kang, CK; Kim, MS; Kim, NJ; Park, KJ; Yoon, SS1
Chen, W; Goldman, GH; Li, R; Li, Y; Liang, T; Liu, W; Osherov, N; Verweij, PE; Wan, Z; Wang, Q; Zheng, B1
Eguchi, K; Ishimura, M; Kamei, K; Kibe, Y; Motomura, Y; Ohga, S; Shiraishi, A; Yada, Y1
Faeli, L; Ghafari, R; Mirzakhani, R; Moslemi, A; Nabati, M; Najafi, N; Salimi, M; Shayesteh Azar, S; Shokohi, T1
Dobashi, A; Imai, M; Imoto, W; Kakeya, H; Kakuno, S; Mitani, K; Niki, M; Ogawa, M; Shibata, W; Takayama, N; Yamada, K1
Chiappini, E; Galli, L; Motisi, MA; Pellegrino, R; Taccetti, G; Terlizzi, V1
Huang, Q; Lu, X; Wu, Y; Xia, L1
Chastain, DB; Henao-Martínez, AF; Thompson, GR1
Ao, W; Fu, B; Fu, X; Huang, P; Wang, J1
Endo, Y; Fujimoto, S; Fujisaki, I; Hosoda, C; Kinoshita, A; Kiritani, A; Kuwano, K; Miyagawa, H; Saito, K; Seki, Y; Takeda, H; Watanabe, N; Yamanaka, Y1
Azoulay, E; Calvet, L; Darmon, M; De Jong, A; Kerhuel, L; Lemiale, V; Mokart, D; Moreau, AS; Pardo, E; Stoclin, A; Valade, S1
Cho, SY; Jung, JI; Lee, DG; Lee, KY; Park, YJ; Yi, Y1
Harada, S; Hayama, B; Kamei, K; Mitani, H; Nakano, K; Ohkushi, D; Yamamoto, Y1
Brooks, JS; Grant, M; Husson, MA; Khan, SN; Leahy, K; Manur, R1
Aram, JA; Freivogel, K; Lem, J; Lewis, A; Moosavi, S; Sobel, RE; Younus, M1
Han, CS; Jia, MY; Zhang, SN1
Arendrup, MC; Helleberg, M; Steensen, M1
Bang, JH; Choe, PG; Jun, KI; Kang, CK; Kim, ES; Kim, H; Kim, HB; Kim, NJ; Oh, MD; Park, SW; Park, WB; Shin, DH; Song, KH; Yoo, SJ1
Bene, P; Dixit, D; Flenaugh, E; Khan, I; Kuete, NT; Oprea-Ilies, G1
Angarone, M; Flaherty, JD; Mylvaganam, R; Peigh, G; Quaggin-Smith, J; Witting, C1
Ben-Ami, R; Diego Vélez, J; Grandhi, A; Haider, S; Han, S; Karthaus, M; Klimko, N; Koh, LP; Lee, DG; Maertens, JA; Motyl, MR; Ponce-de-León, A; Raad, I; Rahav, G; Ramírez Sánchez, IC; Sonet, A; Waskin, H; Zhou, J1
Benoit, P; Ferreira, V; Grandjean Lapierre, S; Halwagi, A; HÉtu, PO; Mathieu, A; Thiboutot, Z1
Deokar, K; Goel, R; Jain, A; Shadrach, BJ1
Aguado, JM; Arnaiz, F; Bodro, M; Calvo, J; Cantón, R; Cifrian, JM; Corbella, L; Fariñas, MC; Fernández-Cruz, A; Fernández-Ruiz, M; Filigheddu, E; Fortún, J; Gioia, F; Gonzalez-Rico, C; Linares, L; López-Medrano, F; López-Soria, LM; Machado, M; Martin-Davila, P; Montejo, JM; Moreno, A; Moreno, S; Muñoz, P; Pérez, S; Pérez-Ayala, A; Ras, MM; Rodríguez-Alvarez, RJ; Sabe, N; Torre-Cisneros, J; Valerio, M; Vidal, E1
Chandrasekar, P; Pasula, S1
Ito, S; Machida, H; Miyairi, I; Tetsuka, N; Yaguchi, T1
Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE1
Birch, M; Buil, JB; Law, D; Meis, JF; Melchers, WJG; Rijs, AJMM; Verweij, PE1
Blot, S; Bulpa, P; Dimopoulos, G; Gomes, A; Meersseman, W; Mergulhão, P; Misset, B; Paiva, JA; Rello, J; Taccone, FS; Van den Abeele, AM; Vogelaers, D1
Bader, O; Baretton, G; Buchheidt, D; Geibel, S; Groß, U; Jacobs, E; Ostrosky-Zeichner, L; Rößler, S; Sommer, U; Spiess, B; Stölzel, F1
Kim, SH; Park, SY; Yoon, JA1
Box, H; Colombo, AL; Hope, WW; Johnson, A; Kolamunnage-Dona, R; Livermore, J; McEntee, L; Negri, CE; Ramos-Martín, V; Schwartz, JA; Whalley, S1
Chen, J; Hu, J; Liu, X; Su, H; Tong, J; Xiao, L; Yang, H; Zhang, L1
Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A1
Goldraich, L; Husain, S; Kabbani, D; Ross, H; Rotstein, C1
Cabanes, L; Martinez Moragón, E; Plaza, P1
Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Hope, W; Kontoyiannis, DP; Lademacher, C; Lortholary, O; Mullane, K; Patterson, TF; Selleslag, D1
Murar, AK; Ojha, UC; Pal, RS; Spalgais, S1
Chen, J; Chen, Y; Gao, J; He, Q; Hou, J; Li, Y; Liu, S; Qi, T; Wen, W; Wu, Y; Yu, R; Zhang, Q; Zhou, F; Zhu, C1
Fujioka, N; Iijima, Y; Kakizaki, Y; Kobayashi, Y; Miyashita, Y; Tsutsui, T; Uchida, Y1
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A1
Ishiguro, T; Kagiyama, N; Kojima, A; Kurashima, K; Nakamoto, Y; Shimizu, Y; Takaku, Y; Takayanagi, N; Yamada, M1
Ashworth, A; Barker, J; Felton, TW; Foden, P; Geraghty, CG; Muldoon, EG; Richardson, MD; Rodriguez-Goncer, I; Thomas, S1
Belderbos, S; Brock, M; Hillen, A; Himmelreich, U; Holvoet, B; Lagrou, K; Maertens, J; Poelmans, J; Vande Velde, G; Vanherp, L; Zhai, L1
Alanio, A; Bretagne, S; Catherinot, E; Garcia-Hermoso, D; Jullien, V; Lortholary, O; Pilmis, B; Scemla, A1
Landsberg, D; Leung, M; Poinen, K; Wright, AJ1
Chen, L; Dong, H; Dong, Y; Lei, J; Li, Y; Meng, T; Wang, T; Yang, Q; Zhang, T1
Chakrabarti, A; Kaur, H; Rudramurthy, SM; Singh, M; Singh, S1
Chaftari, AM; Dandachi, D; Fernández-Cruz, A; Hachem, R; Jiang, Y; Raad, I; Wilson Dib, R1
Bentvelsen, RG; de Haan, AF; Kuiper, EJ; Lestrade, PP; Melchers, WJG; Rijnders, BJA; Schalekamp, S; Schauwvlieghe, AFAD; van der Beek, MT; van der Hoeven, HL; van der Hoven, B; van der Lee, HA; van der Velden, WJFM; van Paassen, J; Verweij, PE1
Foerster, KI; Mahmoudi, M; Mikus, G; Seeßle, J; Vay, M1
Aït-Ammar, N; Botterel, F; Dannaoui, E; Foulet, F; Imbert, S; Levesque, E; Murat, JB1
Chaftari, AM; Dib, RW; Ghaly, F; Hachem, RY; Jiang, Y; Raad, I1
Brüggemann, RJ; Hanff, LM; Henriet, S; Koch, BCP; Lempers, VJ; Mavinkurve-Groothuis, AM; Meuwese, E; van der Sluis, IM; Warris, A1
Begic, E; Cickusic, A; Halilovic, MA; Karasalihovic, Z; Mujkanovic, A; Nislic, E; Trnacevic, A; Trnacevic, S1
Araki, K; Fujimoto, K; Kamei, K; Konishi, M; Maeshima, A; Oshima, H; Oyamada, Y; Tsukamoto, M; Ushikubo, M; Yagi, K1
Hakkouni, AE; Mansouri, N1
Lu, X; Moon, C; Su, Y; Watts, AB; Williams, RO1
Aram, JA; Chen, X; Jin, J; Liu, Y; Lou, YJ; Meng, H; Pan, S; Patterson, TF; Schwartz, IS; Wu, D; Yan, JL; Zhang, X1
Fukuda, Y; Hamano, Y; Iizuka, H; Inano, T; Izumi, H; Nakamura, N; Noguchi, M; Okubo, M; Sakajiri, S; Sawada, T; Sekiguchi, Y; Sugimoto, K; Takizawa, H; Tomita, S; Wakabayashi, M1
Aram, JA; Lee, DG; Lee, HJ; Lin, SS; Yan, JL1
Hu, LF; Lin, GY; Liu, YJ; Pan, XF; Shi, DW; Xu, RA; Ye, XL; Zhang, CH; Zhang, XH1
Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK1
da Trindade, MC; de Menezes, AI; de Souza, DW; Dos Santos, VM; Nascimento, AL; Oguma, PM1
Bobek-Billewicz, B; Foroncewicz, B; Jarząb, B; Krawczyk, M; Mucha, K; Orłowski, T; Pączek, L; Raczyńska, J; Religioni, J1
Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C1
Chen, J; Huang, J; Li, L; Yang, Q1
Clements, RM; Estrada, L; Jon, CK; Mosquera, RA1
Lo, CH; Wu, SW1
Blot, SI; Charles, PE; Dimopoulos, G; Martin, C; Meersseman, W; Pérez, M; Rao, R; Rello, J; Spapen, H; Spapen, J; Taccone, FS; Vogelaers, D1
Sun, H; Zhuo, J1
Annaert, P; de Loor, H; Lagrou, K; Maertens, J; Spriet, I; Vanstraelen, K; Vercammen, I; Wauters, J1
Han, X; Huang, G; Li, W; Liu, Q; Meng, M; Ni, X; Wang, J; Wei, Z; Yang, X; Ye, X; Zheng, A1
Donnelly, JP; Herbrecht, R; Johnson, EM; Maertens, J; Marchetti, O; Pappas, PG; Patterson, TF; Schlamm, HT; Slavin, MA1
Hachem, R; Helou, GE; Jiang, Y; Kontoyiannis, DP; Raad, II; Zakhem, AE1
Cheng, Y; Mu, X; Nie, L; Wang, G; Yu, J1
Choi, SH; Hong, HL; Jung, J; Kim, SH; Kim, YS; Lee, SO; Woo, JH1
Hu, F; Lin, H; Lu, K; Shen, C; Song, X; Tan, M; Wang, C; Xie, S; Xu, L; Yuan, Q; Zhang, Y1
Marr, K; Ostrander, D; Shoham, S1
Arav-Boger, R; Dabb, A; Hsu, AJ1
Chiu, I; Fuller, J; Remington, TL1
Costagliola, D; de Castro, N; Denis, B; Guiguet, M; Lortholary, O; Mechaï, F; Melica, G; Revest, M1
Shah, M; Singhal, P1
Ahn, KS; Hwang, JS; Jang, BK; Kang, KJ; Kang, YN; Kim, HT; Kim, IM; Kim, TS; Kim, YH1
Borobia, AM; Carcas-Sansuán, A; Cendejas-Bueno, E; Escosa-García, L; García-Rodriguez, J; Gomez-Lopez, A; Plaza, D; Río-García, M1
Gonzalez, BE; Gordon, SM; Hanna, R; Hicks, JK; Kusick, K; Murthy, S; Raja, S; Zembillas, AS1
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, SB; Kim, SH; Lee, DG; Lee, HJ; Lee, JW; Park, SH; Yoo, JH1
Chandrasekar, PH; Levine, MT1
Bouza, E; Escribano, P; Guinea, J; Montilla, P; Muñoz, P; Padilla, B1
Buscemi, C; Corrao, S; Imburgia, C1
Marzani, FC; Mojoli, F; Tavazzi, G; Via, G1
Chen, L; Dong, Y; Lei, J; Li, Y; Meng, T; Wang, T; Wang, Y; Xing, J; Yang, Q; Zhang, T1
Barac, A; Dudvarski-Ilic, A; Rubino, S; Stevanovic, G; Vukicevic, TA; Zugic, V1
Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W1
Chemaissani, A; Ernestus, K; Kamp, M; Knüttgen, D; Matten, J; Sakka, SG; Ströhlein, M; Wappler, F1
Bosselmann, S; Coalson, JJ; Nelson, NA; Peters, JI; Tolman, JA; Wiederhold, NP; Williams, RO1
Baert, K; Beernaert, LA; Chiers, K; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L1
Eberhardt, R; Ebinger, D; Eckerle, I; Eisenbach, C; Gotthardt, D; Junghanss, T; Schnabel, PA; Stremmel, W1
Ader, F; Bienvenu, AL; Nseir, S; Rammaert, B1
Karaahmet, T; Korten, V; Odabasi, Z; Tigen, E; Tigen, K1
Hirano, T; Imai, K; Kagawa, K; Kasai, M; Kiyama, Y; Kobayashi, K; Kobayashi, N; Miyazono, T; Ogasawara, M; Tanimoto, M1
Gómez-Bueno, M; Lázaro, MT; Pulpón, L; Ramos, A; Salas, C; Sanchez, I; Segovia, J1
Meletiadis, J; Pournaras, S; Roilides, E; Walsh, TJ1
Alvarez, M; Attal, M; Cassaing, S; Chabrol, A; Cuzin, L; Giron, J; Huguet, F; Linas, MD; Récher, C; Tetu, L; Verdeil, X1
Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A1
Akashi, K; Aoki, T; Harada, N; Iwasaki, H; Kamezaki, K; Miyamoto, T; Mori, Y; Nagafuji, K; Shimono, N; Takenaka, K; Teshima, T; Yamauchi, T; Yoshimoto, G1
Jensen, SG; Nielsen, TL1
Kim, A; Kuti, JL; Nicolau, DP1
Clancy, CJ; Cline, C; Jantz, MA; Kulkarni, V; Leather, H; Nguyen, MH; Wheat, LJ; Wingard, JR1
Deeren, D1
Chai, LY; Hsu, LY1
Ahmad, S; Chandra, J; Chowdhary, A; Kathuria, S; Khan, ZU; Khanna, G; Randhawa, HS; Roy, P; Singh, V1
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC1
Karthaus, M1
Maschmeyer, G; Sandherr, M1
Clemons, KV; Schwartz, JA; Stevens, DA1
Bhagwat, K; Brooks, M; Eisen, D; Royse, A; Royse, C; Sparks, P1
Ko, WC; Lee, HC; Lo, HJ; Wu, CJ1
Choi, SM; Kang, MK; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Min, WS1
Akalin, H; Dizdar, OS; Ener, B; Ersoy, A; Koc, AO1
Beiras-Fernandez, A; Bigdeli, AK; Kaczmarek, I; Michel, S; Nickel, T; Reichart, B; Ueberfuhr, P1
Chang, TC; Hsiue, HC; Hsiue, YC; Hsueh, PR; Huang, YT; Lee, PI; Wu, TH1
Choi, SH; Hong, SB; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lee, SO; Lim, CM; Woo, JH1
Falcone, M; Mancini, C; Morelli, A; Russo, A; Vena, A; Venditti, C; Venditti, M1
Rocha, L; Saleiro, S1
Wintenberger, C1
Briegel, J; Chouker, A; Frey, L; Kaufmann, I; Mayr, D; Spiekermann, K; Thiel, M; van der Heide, V1
Bocanegra, R; Kirkpatrick, WR; Kugler, AR; Najvar, LK; Patterson, TF; Perkins, K; Pfeiffer, J; Sweeney, TD; Vallor, AC; Wiederhold, NP1
Benjamin, DK; Blaschke, AJ; Cohen-Wolkowiez, M; Doby, EH; Driscoll, TA; Martin, PL; Moran, C; Pavia, AT; Ward, RM1
Babor, F; Borkhardt, A; Janßen, G; Laws, HJ; Mackenzie, C; Meisel, R; Sabir, H; Schaper, J; Schuster, F; Siepermann, M; Wessalowski, R1
Egerer, G1
Baghaei, P; Droudinia, A; Javanmard, P; Mansouri, D; Marjani, M; Najafizadeh, K; Sarrafzadeh, SA; Soraghi, A; Tabarsi, P; Zandian, P1
Al-Nakeeb, Z; Arendrup, MC; Cuenca-Estrella, M; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Lass-Flörl, C; Majithiya, JB; Warn, PA1
Choi, SH; Chun, S; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Lee, YJ; Woo, JH1
Al-Nakeeb, Z; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Warn, PA1
Beltran, C; Bourge, RC; Bourke, P; Castro, P; Rabagliati, R; Verdejo, H; Winter, JL1
Atalay, MA; Koç, N; Sav, H; Unal, E1
Li, L; Ling, Z; Shao, F; Sheng, J; Wu, Z1
Abdulaziz, S; Al Jahdali, H; Baharoon, S1
Arabia, FA; Blair, JE; Kusne, S; Scott, RL; Steidley, DE; Vikram, HR; Webb, BJ1
Li, R; Mu, X; Yu, J1
Shi, Y; Sun, HM; Xu, XY; Zhao, BL1

Reviews

11 review(s) available for voriconazole and Allergic Bronchopulmonary Mycosis

ArticleYear
Management of pulmonary aspergillosis in children: a systematic review.
    Italian journal of pediatrics, 2023, Mar-28, Volume: 49, Issue:1

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Mannans; Pulmonary Aspergillosis; Sensitivity and Specificity; Voriconazole

2023
Voriconazole-refractory invasive aspergillosis.
    The Korean journal of internal medicine, 2017, Volume: 32, Issue:5

    Topics: Antifungal Agents; Aspergillus; Biopsy; Coinfection; Cytochrome P-450 CYP2C19; Diagnosis, Differential; Diagnostic Errors; Drug Monitoring; Drug Resistance, Fungal; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pharmacogenetics; Pharmacogenomic Variants; Predictive Value of Tests; Tomography, X-Ray Computed; Voriconazole

2017
Invasive pulmonary aspergillosis due to Aspergillus lentulus in an adult patient: A case report and literature review.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:7

    Topics: Aged, 80 and over; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antifungal Agents; Aspergillus; Bronchoscopy; Fatal Outcome; Female; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lung; Tomography, X-Ray Computed; Voriconazole

2019
Cryptogenic organizing pneumonia associated with invasive pulmonary aspergillosis: a case report and review of the literature.
    International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:12

    Topics: Adrenal Cortex Hormones; Antifungal Agents; Cryptogenic Organizing Pneumonia; Fatal Outcome; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Voriconazole

2014
Adverse effects of voriconazole: Over a decade of use.
    Clinical transplantation, 2016, Volume: 30, Issue:11

    Topics: Adult; Alopecia; Antifungal Agents; Arrhythmias, Cardiac; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Head and Neck Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Nail Diseases; Nervous System Diseases; Periostitis; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Voriconazole

2016
Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature.
    Malaria journal, 2009, Jul-20, Volume: 8

    Topics: Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Malaria, Falciparum; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2009
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
    International journal of chronic obstructive pulmonary disease, 2009, Volume: 4

    Topics: Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2009
Recent advances in invasive pulmonary aspergillosis.
    Current opinion in pulmonary medicine, 2011, Volume: 17, Issue:3

    Topics: Antifungal Agents; Biomarkers; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lectins, C-Type; Mannans; Membrane Proteins; Nerve Tissue Proteins; Polymorphism, Genetic; Pyrimidines; Toll-Like Receptor 4; Triazoles; Voriconazole

2011
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
    European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole

2011
Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.
    European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4

    Topics: Antifungal Agents; Drug Interactions; Humans; Invasive Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole

2011
Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
    Journal de mycologie medicale, 2013, Volume: 23, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchiolitis; Bronchoscopy; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Lung; Male; Pyrimidines; Sputum; Tomography, X-Ray Computed; Triazoles; Tuberculosis, Pulmonary; Voriconazole; Young Adult

2013

Trials

6 trial(s) available for voriconazole and Allergic Bronchopulmonary Mycosis

ArticleYear
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
    Lancet (London, England), 2021, 02-06, Volume: 397, Issue:10273

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antifungal Agents; Double-Blind Method; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Triazoles; Voriconazole; Young Adult

2021
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
    The Journal of antimicrobial chemotherapy, 2018, 03-01, Volume: 73, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Aspergillus; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neutropenia; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole

2018
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
    BMC infectious diseases, 2019, May-28, Volume: 19, Issue:1

    Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole

2019
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.
    Mycoses, 2019, Volume: 62, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Asian People; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Placebos; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult

2019
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for R
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Mar-01, Volume: 60, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult

2015
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2011

Other Studies

129 other study(ies) available for voriconazole and Allergic Bronchopulmonary Mycosis

ArticleYear
Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Invasive Pulmonary Aspergillosis; Mice; Mice, Inbred ICR; Pyrimidines; Triazoles; Voriconazole

2009
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada.
    Expert review of pharmacoeconomics & outcomes research, 2022, Volume: 22, Issue:5

    Topics: Antifungal Agents; Aspergillosis; Canada; Cost-Benefit Analysis; Humans; Invasive Pulmonary Aspergillosis; Nitriles; Pyridines; Triazoles; Voriconazole

2022
COVID-19-associated subacute invasive pulmonary aspergillosis.
    Mycoses, 2022, Volume: 65, Issue:1

    Topics: Adult; Antibodies, Fungal; Aspergillus; COVID-19; Humans; Immunoglobulin G; Invasive Pulmonary Aspergillosis; Middle Aged; Voriconazole

2022
Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia: A case report.
    Medicine, 2022, Jan-28, Volume: 101, Issue:4

    Topics: Adult; Antifungal Agents; fms-Like Tyrosine Kinase 3; Humans; Intestinal Perforation; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Micafungin; Pyrimidines; Thoracic Injuries; Triazoles; Voriconazole

2022
Triazole-resistant
    Emerging microbes & infections, 2022, Volume: 11, Issue:1

    Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; China; Drug Resistance, Fungal; Fermentation; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Triazoles; Voriconazole

2022
Post-transplant Schizophyllum commune abscess in a pediatric patient with chronic granulomatous disease.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2

    Topics: Abscess; Child; Granulomatous Disease, Chronic; Humans; Invasive Pulmonary Aspergillosis; Male; Schizophyllum; Voriconazole

2023
Post-COVID-19 fatal Aspergillus endocarditis: A case report.
    Journal of clinical laboratory analysis, 2023, Volume: 37, Issue:1

    Topics: Aspergillus; COVID-19; Endocarditis; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Voriconazole

2023
Characterization of Aspergillus spp. isolated from patients with coronavirus disease 2019.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:6

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Voriconazole

2023
Case report: nanopore targeted sequencing in the diagnosis of invasive pulmonary Aspergillus infection in a patient with acute promyelocytic leukemia.
    Hematology (Amsterdam, Netherlands), 2023, Volume: 28, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Promyelocytic, Acute; Nanopores; Quality of Life; Voriconazole

2023
Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study.
    Antimicrobial agents and chemotherapy, 2023, 10-18, Volume: 67, Issue:10

    Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Voriconazole

2023
Fatal invasive pulmonary aspergillosis in non-immunocompromised host: A case report.
    Medicine, 2023, Oct-27, Volume: 102, Issue:43

    Topics: Adult; Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Voriconazole

2023
A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:2

    Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Invasive Pulmonary Aspergillosis; Male; Micafungin; Middle Aged; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2020
Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.
    Intensive care medicine, 2019, Volume: 45, Issue:12

    Topics: Adult; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mortality; Retrospective Studies; Survival Rate; Voriconazole

2019
Invasive Pulmonary Aspergillosis Due to Aspergillus awamori: Role of Calcium Oxalate Crystal Precipitation Mimicking Mucormycosis.
    Mycopathologia, 2020, Volume: 185, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biomarkers; Burkitt Lymphoma; Calcium Oxalate; Diagnosis, Differential; Genes, Fungal; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Middle Aged; Mucormycosis; Voriconazole

2020
Fatal invasive pulmonary aspergillosis caused by voriconazole-resistant Aspergillus tubingensis in a patient with solid tumor.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:3

    Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fatal Outcome; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Middle Aged; Tongue Neoplasms; Voriconazole

2020
Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient.
    BMC infectious diseases, 2020, Jan-06, Volume: 20, Issue:1

    Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Combined Modality Therapy; Debridement; Drug Resistance, Fungal; Endoscopy; Female; Humans; Invasive Pulmonary Aspergillosis; Nasopharynx; Trachea; Treatment Outcome; Voriconazole

2020
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
    Pharmaceutical medicine, 2019, Volume: 33, Issue:2

    Topics: Antifungal Agents; Carcinoma, Squamous Cell; Checklist; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Dermatitis, Phototoxic; Drug-Related Side Effects and Adverse Reactions; European Union; Health Care Surveys; Health Personnel; Humans; Invasive Pulmonary Aspergillosis; Mycoses; Pamphlets; Pharmacovigilance; Risk Reduction Behavior; Self Report; Skin Neoplasms; Voriconazole

2019
Integrated Chinese and Western Medicines Shorten Treatment Course of Subacute Invasive Pulmonary Aspergillosis: A Case Report.
    Chinese journal of integrative medicine, 2020, Volume: 26, Issue:4

    Topics: Antifungal Agents; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Male; Medicine, Chinese Traditional; Middle Aged; Voriconazole

2020
Invasive aspergillosis in patients with severe COVID-19 pneumonia.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:1

    Topics: Antifungal Agents; COVID-19; Denmark; Extracorporeal Membrane Oxygenation; Female; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Voriconazole

2021
Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis.
    Scientific reports, 2020, 09-30, Volume: 10, Issue:1

    Topics: Aged; Antifungal Agents; Drug Administration Schedule; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Recurrence; Republic of Korea; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Voriconazole

2020
Invasive Pulmonary Aspergillosis with Hydropneumothorax in a Patient Taking High-Dose Glucocorticoids.
    The American journal of case reports, 2020, Dec-28, Volume: 21

    Topics: Aged; Antifungal Agents; Female; Glucocorticoids; Humans; Hydropneumothorax; Invasive Pulmonary Aspergillosis; Voriconazole

2020
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report.
    Diagnostic microbiology and infectious disease, 2021, Volume: 99, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antiviral Agents; Aspergillus; COVID-19 Drug Treatment; Humans; Immunomodulation; Invasive Pulmonary Aspergillosis; Male; Micafungin; Opportunistic Infections; Receptors, Interleukin-6; SARS-CoV-2; Voriconazole

2021
Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report.
    ASAIO journal (American Society for Artificial Internal Organs : 1992), 2022, 03-01, Volume: 68, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Extracorporeal Membrane Oxygenation; Humans; Invasive Pulmonary Aspergillosis; Voriconazole

2022
Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus.
    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2021, Apr-06, Volume: 91, Issue:2

    Topics: Antifungal Agents; Coinfection; COVID-19; Critical Care; Female; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Obesity, Morbid; SARS-CoV-2; Treatment Outcome; Voriconazole

2021
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study).
    Mycoses, 2021, Volume: 64, Issue:11

    Topics: Adult; Antifungal Agents; Causality; Cohort Studies; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Organ Transplantation; Retrospective Studies; Sensitivity and Specificity; Spain; Voriconazole; Young Adult

2021
Spontaneous Hemoptysis in a Patient With COVID-19.
    Chest, 2021, Volume: 160, Issue:1

    Topics: Aged; Antifungal Agents; Aspergillus niger; Clinical Deterioration; COVID-19; Critical Illness; Critical Pathways; Diagnosis, Differential; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Pseudomonas aeruginosa; Radiography, Thoracic; Respiration, Artificial; SARS-CoV-2; Superinfection; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2021
Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus.
    Pediatrics international : official journal of the Japan Pediatric Society, 2017, Volume: 59, Issue:3

    Topics: Antifungal Agents; Aspergillus; Child; Drug Resistance, Fungal; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Voriconazole

2017
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jul-15, Volume: 65, Issue:2

    Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2017
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9

    Topics: Acetamides; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Nitriles; Piperazines; Point Mutation; Pyridines; Pyrimidines; Pyrroles; Triazoles; Voriconazole

2017
Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
    International journal of antimicrobial agents, 2017, Volume: 50, Issue:4

    Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus; Clinical Decision-Making; Critical Illness; Delayed Diagnosis; Drug Therapy, Combination; Echinocandins; Female; Fungal Proteins; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prognosis; Respiratory System; Treatment Outcome; Voriconazole

2017
Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8

    Topics: Aged; Alleles; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Mutation; Treatment Outcome; Triazoles; Voriconazole

2017
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
    The Journal of infectious diseases, 2018, 03-13, Volume: 217, Issue:7

    Topics: Acetamides; Animals; Antifungal Agents; Aspergillus flavus; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Invasive Pulmonary Aspergillosis; Mice; Piperazines; Pyrimidines; Pyrroles; Triazoles; Voriconazole

2018
Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.
    Medicine, 2017, Volume: 96, Issue:42

    Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Drug Monitoring; Humans; Invasive Pulmonary Aspergillosis; Liver Failure; Male; Treatment Outcome; Voriconazole; Young Adult

2017
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
    Mycoses, 2018, Volume: 61, Issue:3

    Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2018
Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Asymptomatic Diseases; Cohort Studies; Disease Outbreaks; Echinocandins; Female; Galactose; Heart Transplantation; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Mass Screening; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplant Recipients; Voriconazole

2018
Chronic necrotizing pulmonary aspergillosis in an immunocompetent patient.
    Medicina clinica, 2018, 06-08, Volume: 150, Issue:11

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Bronchoscopy; Female; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Voriconazole

2018
Invasive Aspergillus Pseudomembranous and Obstructive Tracheo-bronchitis in an Immuno-competent Patient.
    The Journal of the Association of Physicians of India, 2017, Volume: 65, Issue:11

    Topics: Airway Obstruction; Antifungal Agents; Aspergillus; Bronchitis; Bronchoscopy; Female; Galactose; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Mannans; Sputum; Tracheitis; Treatment Outcome; Voriconazole; Young Adult

2017
Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis.
    Scientific reports, 2018, 01-17, Volume: 8, Issue:1

    Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Aged, 80 and over; Antifungal Agents; Biomarkers; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prognosis; Severity of Illness Index; Survival Rate; Tomography, X-Ray Computed; Voriconazole; Young Adult

2018
Invasive pulmonary aspergillosis mimicking organizing pneumonia after mTOR inhibitor therapy: A case report.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 69

    Topics: Aged; Aspergillus; Carcinoma, Renal Cell; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Pneumonia; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Treatment Outcome; Voriconazole

2018
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24 Suppl 1

    Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2018
Allergic Bronchopulmonary Mycosis Due to Schizophyllum commune Treated Effectively with Voriconazole.
    Internal medicine (Tokyo, Japan), 2018, Sep-01, Volume: 57, Issue:17

    Topics: Antifungal Agents; Female; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Schizophyllum; Sputum; Voriconazole

2018
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:7

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Immunocompromised Host; Influenza, Human; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Voriconazole; Young Adult

2018
A Multimodal Imaging Approach Enables
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:7

    Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Disease Progression; Invasive Pulmonary Aspergillosis; Leukopenia; Luminescent Measurements; Lung; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred BALB C; Multimodal Imaging; Treatment Outcome; Voriconazole

2018
Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018, Volume: 18, Issue:9

    Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Mutation; Prognosis; Voriconazole

2018
A vexing case of bone pain in a renal transplant recipient: Voriconazole-induced periostitis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:5

    Topics: Antifungal Agents; Drug Substitution; Graft Rejection; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Middle Aged; Periostitis; Transplant Recipients; Triazoles; Voriconazole

2018
A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model.
    Journal of translational medicine, 2018, 06-07, Volume: 16, Issue:1

    Topics: A549 Cells; Aspergillus fumigatus; Biomarkers; Computer Simulation; Dose-Response Relationship, Drug; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Monte Carlo Method; Regression Analysis; Voriconazole

2018
Aspergillus terreus Causing Probable Invasive Aspergillosis in a Patient with Cystic Fibrosis.
    Mycopathologia, 2019, Volume: 184, Issue:1

    Topics: Antifungal Agents; Aspergillus; Child; Cystic Fibrosis; Drug Monitoring; Galactose; Humans; India; Invasive Pulmonary Aspergillosis; Male; Mannans; Treatment Outcome; Voriconazole

2019
Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
    Annals of medicine, 2018, Volume: 50, Issue:8

    Topics: Aged; Antifungal Agents; Aspergillus; Female; Follow-Up Studies; Humans; Immunocompromised Host; Incidence; Invasive Pulmonary Aspergillosis; Lung; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2018
Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 04-24, Volume: 68, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Autoimmune Diseases; Child; Child, Preschool; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Analysis; Time Factors; Voriconazole

2019
No alteration of voriconazole concentration by plasmapheresis in a critically ill patient.
    European journal of clinical pharmacology, 2019, Volume: 75, Issue:2

    Topics: Aged; Antifungal Agents; Critical Illness; Female; Granulomatosis with Polyangiitis; Humans; Invasive Pulmonary Aspergillosis; Plasmapheresis; Voriconazole

2019
Aspergillus pseudodeflectus: a new human pathogen in liver transplant patients.
    BMC infectious diseases, 2018, Dec-12, Volume: 18, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Liver; Liver Transplantation; Microbial Sensitivity Tests; Middle Aged; Transplant Recipients; Voriconazole

2018
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.
    BMC infectious diseases, 2018, Dec-13, Volume: 18, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Empiricism; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Precision Medicine; Prognosis; Retrospective Studies; Standard of Care; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult

2018
Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients.
    Medical mycology, 2019, Nov-01, Volume: 57, Issue:8

    Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Male; Retrospective Studies; Serum; Voriconazole

2019
Invasive Aspergillosis After Kidney Transplant-Treatment Approach.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2018, Volume: 72, Issue:6

    Topics: Adult; Antifungal Agents; Caspofungin; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Plasmapheresis; Pneumonectomy; Postoperative Complications; Tacrolimus; Treatment Outcome; Voriconazole

2018
[Invasive pulmonary aspergillosis in a patient with human immunodeficiency virus (HIV)].
    The Pan African medical journal, 2018, Volume: 31

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; HIV Infections; Humans; Invasive Pulmonary Aspergillosis; Male; Tomography, X-Ray Computed; Voriconazole

2018
Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation.
    Molecular pharmaceutics, 2019, 05-06, Volume: 16, Issue:5

    Topics: Administration, Inhalation; Aerosols; Antifungal Agents; Crystallization; Drug Compounding; Drug Design; Drug Liberation; Drug Stability; Dry Powder Inhalers; Excipients; Feasibility Studies; Humans; Invasive Pulmonary Aspergillosis; Mannitol; Particle Size; Powders; Voriconazole

2019
A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Aspergillus Brain Abscess and Invasive Pulmonary Aspergillosis Successfully Treated with Voriconazole Followed by Cord Blood Transplantation.
    Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:7

    Topics: Antifungal Agents; Brain Abscess; Cord Blood Stem Cell Transplantation; Female; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole

2019
Successful management of voriconazole-associated hyponatremia with therapeutic drug monitoring.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Drug Monitoring; Humans; Hyponatremia; Invasive Pulmonary Aspergillosis; Male; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2013
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013
A 76-year-old man with a right lung adenocarcinoma and invasive Aspergillosis.
    Mycopathologia, 2013, Volume: 176, Issue:1-2

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antifungal Agents; Aspergillus fumigatus; Histocytochemistry; Humans; Invasive Pulmonary Aspergillosis; Lung; Lung Neoplasms; Male; Microscopy; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole

2013
Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient.
    Annals of transplantation, 2013, May-23, Volume: 18

    Topics: Adolescent; Antifungal Agents; Hepatoblastoma; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Liver Neoplasms; Liver Transplantation; Male; Opportunistic Infections; Pyrimidines; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
    Journal of medical virology, 2014, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult

2014
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.
    International journal of medical sciences, 2013, Volume: 10, Issue:12

    Topics: Adult; Antifungal Agents; Cross Infection; End Stage Liver Disease; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Rate; Triazoles; Voriconazole

2013
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
    BMJ case reports, 2013, Nov-18, Volume: 2013

    Topics: Antifungal Agents; beta-Glucans; Biomarkers; Bronchoalveolar Lavage; Child; Cystic Fibrosis; Early Diagnosis; Fatal Outcome; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole

2013
Chronic necrotizing pulmonary aspergillosis.
    QJM : monthly journal of the Association of Physicians, 2014, Volume: 107, Issue:7

    Topics: Aged; Antifungal Agents; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Tomography, X-Ray Computed; Voriconazole

2014
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:2

    Topics: Adult; Aged; Antifungal Agents; Aspergillus; Brain; Cohort Studies; Critical Illness; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Risk Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole

2014
[Caspofungin and voriconazole combination therapy for invasive pulmonary aspergillosis in patients with liver failure: a report of two cases].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014, Volume: 22, Issue:3

    Topics: Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Liver Failure; Male; Middle Aged; Voriconazole

2014
Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Aged; Antifungal Agents; Bilirubin; Blood Proteins; Chromatography, Liquid; Critical Illness; Female; Humans; Hypoalbuminemia; Intensive Care Units; Invasive Pulmonary Aspergillosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Protein Binding; Serum Albumin; Tandem Mass Spectrometry; Voriconazole

2014
Invasive pulmonary aspergillosis: a rare complication after microwave ablation.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2014, Volume: 30, Issue:6

    Topics: Ablation Techniques; Adenocarcinoma; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung Neoplasms; Male; Microwaves; Middle Aged; Voriconazole

2014
Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
    International journal of antimicrobial agents, 2015, Volume: 45, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult

2015
[Mixed types of pulmonary aspergillosis].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2014, Volume: 37, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Glucocorticoids; Humans; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole

2014
Immune reconstitution inflammatory syndrome in neutropenic patients with invasive pulmonary aspergillosis.
    The Journal of infection, 2015, Volume: 70, Issue:6

    Topics: Antifungal Agents; Female; Galactose; Humans; Immune Reconstitution Inflammatory Syndrome; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Middle Aged; Neutropenia; Republic of Korea; Retrospective Studies; Voriconazole

2015
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole

2015
Autoinduction of voriconazole metabolism in a child with invasive pulmonary aspergillosis.
    Pharmacotherapy, 2015, Volume: 35, Issue:4

    Topics: Anemia, Aplastic; Antifungal Agents; Antineoplastic Agents, Alkylating; Child; Cyclophosphamide; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Voriconazole

2015
Chronic necrotizing pulmonary aspergillosis in a patient with diabetes and marijuana use.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015, Nov-17, Volume: 187, Issue:17

    Topics: Adult; Antifungal Agents; Cannabis; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Empyema, Pleural; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Marijuana Smoking; Medical Marijuana; Pneumothorax; Radiography; Volatilization; Voriconazole

2015
Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Oct-15, Volume: 61, Issue:8

    Topics: Adult; Anti-HIV Agents; Antifungal Agents; Aspergillosis; Aspergillus; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; France; HIV Infections; Humans; Invasive Pulmonary Aspergillosis; Male; Medical Records; Middle Aged; Proportional Hazards Models; Survival Rate; Time Factors; Voriconazole

2015
Rare Case: Invasive Pseudomembranous Aspergillus Tracheobronchitis in a Postpartum Patient Presenting With Stridor.
    Journal of bronchology & interventional pulmonology, 2015, Volume: 22, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillus; Biopsy; Bronchitis; Bronchoscopy; Female; Humans; Invasive Pulmonary Aspergillosis; Lung Diseases, Fungal; Postpartum Period; Rare Diseases; Respiratory Sounds; Tracheitis; Voriconazole

2015
Successful Treatment of Combined Aspergillus and Cytomegalovirus Abscess in Brain and Lung After Liver Transplant for Toxic Fulminant Hepatitis.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2017, Volume: 15, Issue:1

    Topics: Antifungal Agents; Biopsy; Brain Abscess; Chemical and Drug Induced Liver Injury; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Liver Transplantation; Lung Abscess; Magnetic Resonance Imaging; Middle Aged; Mushroom Poisoning; Neuroaspergillosis; Neurosurgical Procedures; Opportunistic Infections; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole

2017
Chronic pulmonary aspergillosis: help is on the way.
    The Lancet. Respiratory medicine, 2016, Volume: 4, Issue:2

    Topics: Antifungal Agents; Chronic Disease; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Practice Guidelines as Topic; Pulmonary Aspergillosis; Voriconazole

2016
Invasive aspergillosis in a paediatric allogeneic stem cell transplantation recipient owing to a susceptible Aspergillus fumigatus: Treatment failure with high doses of voriconazole and influence of CYP2C19 polymorphisms.
    International journal of antimicrobial agents, 2016, Volume: 47, Issue:5

    Topics: Antifungal Agents; Aspergillus fumigatus; Child, Preschool; Cytochrome P-450 CYP2C19; Humans; Invasive Pulmonary Aspergillosis; Male; Polymorphism, Genetic; Stem Cell Transplantation; Transplant Recipients; Transplantation, Homologous; Treatment Failure; Voriconazole

2016
Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrations.
    Pharmacogenomics, 2016, Volume: 17, Issue:7

    Topics: Antifungal Agents; Child; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Pharmacogenomic Variants; Precision Medicine; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole

2016
Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study.
    Medical mycology, 2017, Apr-01, Volume: 55, Issue:3

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Female; Humans; Incidence; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prevalence; Retrospective Studies; Survival Analysis; Voriconazole

2017
Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.
    Journal of clinical microbiology, 2017, Volume: 55, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillus fumigatus; Female; Genotype; Graft vs Host Disease; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Typing; Mycological Typing Techniques; Triazoles; Voriconazole

2017
Pulmonary infiltrate with characteristic "reversed halo" and "air crescent" signs.
    European journal of internal medicine, 2017, Volume: 41

    Topics: Antifungal Agents; Aspergillus; Astrocytoma; Bronchoscopy; Combined Modality Therapy; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pancytopenia; Tomography, X-Ray Computed; Voriconazole

2017
Invasive pulmonary aspergillosis after near-drowning.
    The Lancet. Infectious diseases, 2016, Volume: 16, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Near Drowning; Shock, Septic; Voriconazole

2016
Uptake and efflux kinetics, and intracellular activity of voriconazole against Aspergillus fumigatus in human pulmonary epithelial cells: a new application for the prophylaxis and early treatment of invasive pulmonary aspergillosis.
    Fundamental & clinical pharmacology, 2017, Volume: 31, Issue:3

    Topics: A549 Cells; Antibiotic Prophylaxis; Antifungal Agents; Aspergillus fumigatus; Cell Line, Tumor; Epithelial Cells; Half-Life; Humans; Invasive Pulmonary Aspergillosis; Kinetics; Lung; Voriconazole

2017
Subacute invasive pulmonary aspergillosis as a rare cause of pneumothorax in immunocompetent patient: brief report.
    Infection, 2017, Volume: 45, Issue:3

    Topics: Antifungal Agents; Aspergillus fumigatus; Female; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Middle Aged; Pneumothorax; Treatment Outcome; Voriconazole

2017
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole

2009
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].
    Der Anaesthesist, 2009, Volume: 58, Issue:3

    Topics: Abdomen; Antifungal Agents; Caspofungin; Colonic Neoplasms; Critical Illness; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Laparotomy; Lipopeptides; Middle Aged; Peritonitis; Physical Therapy Modalities; Postoperative Complications; Pyrimidines; Sepsis; Triazoles; Voriconazole

2009
Dose tolerability of chronically inhaled voriconazole solution in rodents.
    International journal of pharmaceutics, 2009, Sep-08, Volume: 379, Issue:1

    Topics: Administration, Inhalation; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Invasive Pulmonary Aspergillosis; Lung; Macrophages, Alveolar; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Tissue Distribution; Triazoles; Voriconazole

2009
Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
    Veterinary microbiology, 2009, Nov-18, Volume: 139, Issue:3-4

    Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Columbidae; Invasive Pulmonary Aspergillosis; Liver; Pyrimidines; Triazoles; Voriconazole

2009
Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2009, Volume: 7, Issue:3

    Topics: Acute Disease; Antifungal Agents; Antiviral Agents; Cardiomyopathy, Dilated; Cytomegalovirus Infections; Early Diagnosis; Ganciclovir; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Opportunistic Infections; Pulse Therapy, Drug; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2009
Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia.
    Acta medica Okayama, 2009, Volume: 63, Issue:4

    Topics: Adult; Antifungal Agents; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Biphenotypic, Acute; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2009
Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Female; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Pyrimidines; Tracheitis; Triazoles; Voriconazole

2010
Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Colorimetry; Confidence Intervals; Drug Therapy, Combination; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole

2010
Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
    Haematologica, 2010, Volume: 95, Issue:6

    Topics: Adolescent; Adult; Aged; Air Pollutants; Caspofungin; Cohort Studies; Construction Materials; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2010
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
    Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy.
    Mycoses, 2011, Volume: 54, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Micafungin; Middle Aged; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole

2011
Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
    The clinical respiratory journal, 2008, Volume: 2, Issue:4

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Asthma; Bronchoscopy; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Prognosis; Pyrimidines; Radiography, Thoracic; Recurrence; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2008
Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States.
    Mycoses, 2011, Volume: 54, Issue:5

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Cohort Studies; Echinocandins; Female; Hospital Costs; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Length of Stay; Lipopeptides; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole

2011
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Triazoles; Voriconazole

2011
Treatment of invasive aspergillosis with nonmyeloablative allogeneic stem cell transplantation: one stone two birds.
    Leukemia research, 2011, Volume: 35, Issue:5

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Immunosuppression Therapy; Invasive Pulmonary Aspergillosis; Leukemia; Pyrimidines; Radiography; Remission Induction; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole

2011
Bipolaris hawaiiensis as etiologic agent of allergic bronchopulmonary mycosis: first case in a paediatric patient.
    Medical mycology, 2011, Volume: 49, Issue:7

    Topics: Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus fumigatus; beta-Glucans; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Female; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Mycological Typing Techniques; Phylogeny; Prednisone; Pyrimidines; Sequence Analysis, DNA; Sputum; Treatment Outcome; Triazoles; Voriconazole

2011
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
    Medical mycology, 2011, Volume: 49, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole

2011
An accidental mass.
    Lancet (London, England), 2011, May-21, Volume: 377, Issue:9779

    Topics: Accidents, Traffic; Adult; Aspergillus flavus; Caspofungin; Combined Modality Therapy; Coronary Thrombosis; Diagnosis, Differential; Disease Progression; Echinocandins; Echocardiography; Echocardiography, Transesophageal; Embolism; Emergency Service, Hospital; Endocarditis; Female; Fractures, Bone; Humans; Incidental Findings; Invasive Pulmonary Aspergillosis; Lipopeptides; Mediastinal Diseases; Pelvic Bones; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis.
    Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:4

    Topics: Antifungal Agents; Antigens, Fungal; Drug Monitoring; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole; Young Adult

2011
A case of pseudomembranous colitis after voriconazole therapy.
    Yonsei medical journal, 2011, Volume: 52, Issue:5

    Topics: Adult; Antifungal Agents; Enterocolitis, Pseudomembranous; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2011
Aspergillus fumigatus spondylodiskitis in renal transplant patient: voriconazole experience.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011, Volume: 9, Issue:4

    Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Back Pain; Discitis; Diskectomy; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Tuberculosis, Pulmonary; Voriconazole

2011
Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011, Volume: 9, Issue:4

    Topics: Antifungal Agents; Drug Therapy, Combination; Echinocandins; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2011
Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:7

    Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Incidence; Infant; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Analysis; Taiwan; Triazoles; Voriconazole; Young Adult

2012
Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
    Mycoses, 2012, Volume: 55, Issue:2

    Topics: Aged; Antifungal Agents; Antiviral Agents; Fatal Outcome; Humans; Immunocompetence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Male; Oseltamivir; Pyrimidines; Triazoles; Voriconazole

2012
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Comorbidity; Early Diagnosis; Female; Galactose; Hospital Units; Hospitals, University; Humans; Invasive Pulmonary Aspergillosis; Italy; Leukocyte Count; Male; Mannans; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2011
Invasive pulmonary aspergillosis in a patient with seminomatous testicular cancer.
    Mycoses, 2011, Volume: 54 Suppl 4

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Pyrimidines; Testicular Neoplasms; Treatment Outcome; Triazoles; Voriconazole

2011
[Invasive aspergillosis: new tools for a targeted medical management].
    Medecine et maladies infectieuses, 2011, Volume: 41, Issue:12

    Topics: Adult; Aged; Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Clinical Trials as Topic; Comorbidity; Disease Management; Female; France; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Chronic granulomatous disease in an adult recognized by an invasive aspergillosis.
    The American journal of the medical sciences, 2012, Volume: 343, Issue:2

    Topics: Antifungal Agents; Aspergillus; Diagnosis, Differential; Germany; Granulomatous Disease, Chronic; Humans; Infusions, Parenteral; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Phagocytes; Pyrimidines; Respiratory Insufficiency; Tachypnea; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:4

    Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Chemoprevention; Colony Count, Microbial; Cortisone; Cyclophosphamide; Disease Models, Animal; Guinea Pigs; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung; Male; Pyrimidines; Survival Analysis; Triazoles; Voriconazole

2012
Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:6

    Topics: Antifungal Agents; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Plasma; Pyrimidines; Triazoles; Voriconazole

2012
Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
    Klinische Padiatrie, 2012, Volume: 224, Issue:3

    Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole

2012
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
    Mycoses, 2012, Volume: 55 Suppl 2

    Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole

2012
Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2012, Volume: 10, Issue:3

    Topics: Adult; Antifungal Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Caspofungin; Drug Therapy, Combination; Echinocandins; Galactose; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Transplantation; Triazoles; Voriconazole

2012
Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.
    The Journal of infectious diseases, 2012, Aug-01, Volume: 206, Issue:3

    Topics: Antifungal Agents; Aspergillus fumigatus; Bioreactors; Cell Culture Techniques; Cells, Cultured; Chromatography, High Pressure Liquid; Computer Simulation; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Endothelial Cells; Epithelial Cells; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Models, Biological; Pulmonary Artery; Pyrimidines; Respiratory Mucosa; Triazoles; Voriconazole

2012
Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies.
    Medical mycology, 2013, Volume: 51, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Republic of Korea; Tertiary Care Centers; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2013
Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:10

    Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cell Line; Chromatography, High Pressure Liquid; Drug Interactions; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Models, Theoretical; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole

2012
Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
    Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Debridement; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis

2012
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:4

    Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.
    The Journal of international medical research, 2012, Volume: 40, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Invasive Pulmonary Aspergillosis; Liver Failure, Acute; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole

2012
Combination antifungal therapy for invasive pulmonary aspergillosis.
    BMJ case reports, 2012, Dec-14, Volume: 2012

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

2012
Concurrent pulmonary Aspergillus fumigatus and mucor infection in a cardiac transplant recipient: a case report.
    Transplantation proceedings, 2013, Volume: 45, Issue:2

    Topics: Air Microbiology; Antifungal Agents; Cardiomyopathy, Dilated; Cyclonic Storms; Environmental Exposure; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Pyrimidines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole

2013
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:4

    Topics: Aged; Antifungal Agents; DNA, Fungal; Echinocandins; Emericella; Exudates and Transudates; Galactose; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Microscopy; Molecular Sequence Data; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole

2013